CRA-024781
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CRA-024781, covering 2010-08-25 to 2010-08-25. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients [Phase 1]